Abstract
Dendritic cells (DCs) are potent professional antigen-presenting cells (APC) capable of inducing the primary T cell response to antigen. Although tumor cells express target antigens, they are incapable of stimulating a tumor-specific immune response due to a defect in the costimulatory signal that is required for optimal activation of T cells. In this work, we describe a new approach using tumor-DC coculture to improve the antigen presenting capacity of tumor cells, which does not require a source of tumor-associated antigen. Immunization of a weakly immunogenic and progressive tumor cocultured with bone marrow-derived DCs generated an effective tumor vaccine. Immunization with the cocultured DCs was able to induce complete protective immunity against tumor challenges and was effective for the induction of tumor-specific CTL (cytotoxic T lymphocyte) activity. Furthermore, high NK cell activity was observed in mice in which tumors were rejected. In addition, immunization with tumor-pulsed DCs induced delayed tumor growth, but not tumor eradication in tumor-bearing mice. Our results demonstrate that coculture of DCs with tumors generated antitumor immunity due to the NK cell activation as well as tumor-specific T cell. This approach would be useful for designing tumor vaccines using DCs when the information about tumor antigens is limited.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity.Nature, 392, 245–252 (1998).
Cayeux, S., Richter, G., Becker, C., Pezzutto, A., Dorken, B. and Blankenstein, T., Direct and indirect T cell priming by dendritic cell vaccines.Eur. J. Immunol., 29, 225–234 (1999).
Celluzzi, C. M. and Falo, L. D., Jr., Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection.J. Immunol., 160, 3081–3085 (1998).
Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T. and Falo, L. D., Jr., Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.J. Exp. Med., 183, 283–287 (1996).
Chambers, B. J., Salcedo, M. and Ljunggren, H. G., Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1).Immunity, 5, 311–317 (1996).
De Smedt, T., Pajak, B., Muraille, E., Heinen, E., De Baetselier, P., Urbain, J., Leo, O. and Moser, M., Lipopolysaccaride induces intrasplenic migration and functional maturation of dendritic cells.J. Exp. Med., 184, 1413–1424 (1996).
Gong, J., Chen, D., Kashiwaba, M. and Kufe, D., Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells.Nat. Med., 3, 558–561 (1997).
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G. and Levy, R., Vaccination of patients with B-cell lymphoma using autologous antigen- pulsed dendritic cells.Nat. Med., 2, 52–58 (1996).
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.J. Exp. Med., 176, 1693–1702 (1992).
Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Muramatsu, S., Hodes, R. J. and Steinman, R.M., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dend-ritic cells in situ and during maturation in vitro.J. Exp. Med., 180, 1849–60 (1994).
Jondal, M., Schirmbeck, R. and Reimann, J., MHC class I-restricted CTL responses to exogenous antigens.Immunity, 5, 295–302 (1996).
Kim, T. S. and Cohen E. P., Macrophage-activating factors produced by murine leukemia X fibroblast hybrid cells stimulates resistance toMycobacterium avium complex.Arch. Pharm. Res., 20, 225–233 (1997).
Kos, F. J. and Engleman, E. G., Immune regulation: a critical link between NK cells and CTLs.Immunol. Today, 17, 174–176 (1996).
Macatonia, S. E., Hosken, N. A., Litton, M., Vieira, P., Hsieh, C. S., Culpepper, J. A., Wysocka, M., Trinchieri, G., Murphy, K. M. and O'Garra, A., Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.J. Immunol., 154, 5071–5079 (1995).
Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K. and Gilboa, E., Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.Nat. Biotechnol., 16, 364–369 (1998).
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.Nat. Med., 4, 328–32 (1998).
Porgador, A., Snyder, D. and Gilboa, E., Induction of antitumor immunity using bone marrow-generated dendritic cells.J. Immunol., 156, 2918–2926 (1996).
Rock, K. L., A new foreign policy: MHC class I molecules monitor the outside world.Immunol Today, 17, 131–137 (1996).
Scheicher, C., Mehlig, M., Zecher, R. and Reske, K., Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor.J. Immunol. Methods, 154, 253–264 (1992).
Scheicher, C., Mehlig, M., Zecher, R., Seiler, F., Hintz-Obertreis, P. and Reske, K., Recombinant GM-CSF induces in vitro differentiation of dendritic cells from mouse bone marrow.Adv. Exp. Med. Biol., 329, 269–273 (1993).
Schuler, G. and Steinman, R. M., Dendritic cells as adjuvants for immune-mediated resistance to tumors.J. Exp. Med., 186, 1183–1187 (1997).
Steinman, R. M., The dendritic cell system and its role in immunogenicity.Annu. Rev. Immunol., 9, 271–296 (1991).
Wang, J., Saffold, S., Cao, X., Krauss, J. and Chen, W., Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.J. Immunol., 161, 5516–5524 (1998).
Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J. and Ricciardi-Castagnoli, P., Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures.J. Exp. Med., 185, 317–328 (1997).
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T. and Storkus, W. J., Therapy of murine tumors with tumor peptidepulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.J. Exp. Med., 183, 87–97 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, K.D., Kim, J.K., Kim, SJ. et al. Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation. Arch Pharm Res 22, 340–347 (1999). https://doi.org/10.1007/BF02979055
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02979055